Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft-versus-host disease

American Journal of Hematology

Volumn 78, Issue 4, 2005, Pages 306-309

  Bolaños Meade, Javier ^a   Zhou, Lan ^a   Hoke, Ahmet ^a   Corse, Andrea ^a   Vogelsang, Georgia ^a   Wagner, Kathryn R ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Graft versus host disease; Hydroxychloroquine; Myopathy; Vacuolar myopathy

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; CREATINE KINASE; CYCLOPHOSPHAMIDE; DOXORUBICIN; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOSTATIN; PREDNISOLONE; PREDNISONE; RITUXIMAB; TACROLIMUS; VINCRISTINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOPHAGY; CASE REPORT; CELL VACUOLE; CHRONIC GRAFT VERSUS HOST DISEASE; CREATINE KINASE BLOOD LEVEL; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; HUMAN; MALE; MANTLE CELL LYMPHOMA; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; POLYNEUROPATHY; PRIORITY JOURNAL;

BIOPSY; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; ENZYME INHIBITORS; GRAFT VS HOST DISEASE; HUMANS; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; MUSCLE, SKELETAL; TREATMENT OUTCOME; VACUOLES;

EID: 16344369232     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20294     Document Type: Article

References (18)

1. Gilman AL, Chan KW, Mogul M, et al. Hydroxychloroquine for the treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2000;6(3A):327-334.
2. Gilman AL, Beams F, Tefft M, Mazumder A. The effect of hydroxychloroquine on alloreactivity and its potential use for graft-versus-host disease. Bone Marrow Transplant 1996:17(6):1069-1075.
3. Gottlieb RA, Nordberg J, Skowronski E, Babior BM. Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc Natl Acad Sci USA 1996;93(2):654-658.
4. Goldman FD, Gilman AL, Hollenback C, Kato RM, Premack BA, Rawlings DJ. Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties. Blood 2000;95(11):3460-3466.
5. Fox RI, Kang HI. Mechanism of action of antimalarial drugs: inhibition of antigen processing and presentation. Lupus 1993;2(Suppl 1):S9-S12.
6. Schultz KR, Gilman AL. The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease. Leuk Lymphoma 1997;24(3-4):201-210.
7. Bondeson J, Sundler R. Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1beta and tumor necrosis factor alpha in macrophages: implications for their mode of action in rheumatoid arthritis. Gen Pharmacol 1998;30(3):357-366.
8. Schultz KR, Su WN, Hsiao CC, et al. Chloroquine prevention of murine MHC-disparate acute graft-versus-host disease correlates with inhibition of splenic response to CpG oligodeoxynucleotides and alterations in T-cell cytokine production. Biol Blood Marrow Transplant 2002;8(12):648-655.
9. Hsiao CC, Su WN, Forooghian F, et al. Evaluation for synergistic suppression of T cell responses to minor histocompatibility antigens by chloroquine in combination with tacrolimus and a rapamycin derivative, SDZ-RAD. Bone Marrow Transplant 2002;30(12): 905-913.
10. Schultz KR, Su WN, Bader S, Rempel J, HayGlass KT. Synergistic suppression of T cell responses by chloroquine and tacrolimus to minor and major histocompatibility antigens. Exp Hematol 1998;26(8):778.
11. Stein M, Bell MJ, Ang LC. Hydroxychloroquine neuromyotoxicity. J Rheumatol 2000;27(12):2927-2931.
12. Estes ML, Ewing-Wilson D, Chou SM, et al. Chloroquine neuromyotoxicity. Clinical and pathologic perspective. Am J Med 1987;82(3):447-455.
13. Kuncl RW, Wiggins WW. Toxic myopathies. Neurol Clin 1988;6(3):593-619.
14. McChesney EW, Banks WF Jr, Fabian RJ. Tissue distribution of chloroquine, hydroxychloroquine, and desethylchloroquine in the rat. Toxicol Appl Pharmacol 1967;10(3):501-513.
15. McChesney EW. Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate. Am J Med 1983;75(1A):11-18.
16. Borden MB, Parke AL. Antimalarial drugs in systemic lupus erythematosus: use in pregnancy. Drug Saf 2001;24(14):1055-1063.
17. Sundelin SP, Terman A. Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells. APMIS 2002;110(6):481-489.
18. Vogelsang GB, Lee L, Bensen-Kennedy DM. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med 2003;54:29-52.